FDA issued a Warning Letter to PharMEDium Services, LLC on 4/13/2007 for a previous inspection.
483 PharMEDium Services Feb 2013

483 PharMEDium Services Feb 2013

Russell Glapion FDA, James Liubicich FDA$119.00 - Available Now

FDA investigators audited the PharMEDium Services - Dayton, NJ, United States facility and issued 7 inspectional observations (via FDA 483) on 28 Feb 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 7
  • Inspection end: 28 Feb 2013
  • Location: Dayton, United States
  • FEI: 2242985
Add To Cart